Nano Letters · 2019 · 202 citations · 24 references
PharmacyImmunologyPharmaceuticsNanobiotechnologyNanotechnologyVaccinologyCell-nanoparticle InteractionsNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsVaccine DeliveryAntigen-specific Antibody ResponsesHumoral Immune EnhancementNanoparticle Size EffectsNanoparticle Uptake By Immune CellsNanoparticle Vaccine DeliveryNanoparticle Vaccine FormulationsNanoparticle Vaccine PlatformsNanoparticles
Lymph node follicles capture and retain antigens to induce germinal centers and long-lived humoral immunity. However, control over antigen retention has been limited. Here we discovered that antigen conjugated to nanoparticle carriers of different sizes impacts the intralymph node transport and specific cell interaction. We found that follicular dendritic cell (FDC) networks determine the intralymph node follicle fate of these nanoparticles by clearing smaller ones (5-15 nm) within 48 h and retaining larger ones (50-100 nm) for over 5 weeks. The 50-100 nm-sized nanoparticles had 175-fold more delivery of antigen at the FDC dendrites, 5-fold enhanced humoral immune responses of germinal center B cell formation, and 5-fold more antigen-specific antibody production over 5-15 nm nanoparticles. Our results show that we can tune humoral immunity by simply manipulating the carrier size design to produce effectiveness of vaccines.
24
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity
Paul W. Dempsey, Michael Allison, Srinivas Akkaraju et al. · Science · 1996 · 1.2K citations
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi, Ioanna Skountzou, Randy A. Albrecht et al. · Nature · 2011 · 974 citations · Full text